1. a) Where is the Comoros?
b) What is the population of the Comoros?

2. a) Define controversial.
b) Why is the test of a malaria drug in the Comoros controversial?

3. How does Chinese pharmaceutical company Artepharm’s Artequick differ from the usual Western method of fighting malaria?

4. What is the theory behind the use of a drug like Artequick?
b) What problem do you think could likely occur with this procedure?

5. How is Artepharm marketing Artequick throughout Africa?

6. What problems did many people in the Comoros experience after being given Artequick?

7. What does the World Health Organization (WHO) say the Chinese company did not do that it should have when administering this drug to all Comorans?

8. From para. 28: “This drug is safe and effective,” a local doctor shouted through a megaphone, “Some of you think you are being used as guinea pigs. You are not being used as guinea pigs. The WHO would not allow this administration to happen if you were being used as guinea pigs.”
a) Do you think the people of the Comoros were used as guinea pigs? Explain your answer.
b) Would you be a willing participant if the U.S. government made all Americans take part in an experimental treatment for a potentially deadly disease? Explain your answer.
c) Only a few locals told CBS News they were warned of any side effects before taking Artequick. Villagers were also not informed about the risks of Primaquine, a powerful anti-malaria medicine the scientists use in combination with Artequick for this experiment. Primaquine can be lethal — causing red blood cells to rupture — but chief scientist Song Jianping says his team is using it at low, safe levels. Ahead of the second administration, the scientists tried to give people more information. Would you trust the Chinese company Artepharm to be responsible in the way they conducted the test of their malaria drug?